Proactive digs down on the offering from Shield Therapeutics

Shield Therapeutics’ place in the market and possible investment opportunities were explored by Proactive analyst Dr John Savin.

With a huge market in the US ready to be tapped into, Dr Savin explained how Shield is well-placed to make advances with their anaemia treatments, with a comparatively small team making in-roads and the chance to invest more to grab a larger share of the market in future.

You might like

© 2022 Stockmark.it The Latest StockMarket News and Interviews